Résumé
Screening for the risk of fetal aneuploidy can be effectively performed in either the first or second trimester. When obtained independently, the interpretation of those data is straightforward. However, the effectiveness of screening can be enhanced by combining studies performed in each trimester in a variety of ways. In this commentary we will define and discuss both the advantages and disadvantages of using integrated, stepwise, sequential or contingency screening for risk assessment of fetal aneuploidy.
| Langue d'origine | English |
|---|---|
| Pages (de-à) | 715-718 |
| Nombre de pages | 4 |
| Journal | Obstetrics and Gynecology |
| Volume | 107 |
| Numéro de publication | 3 |
| DOI | |
| Statut de publication | Published - mars 2006 |
ASJC Scopus Subject Areas
- Obstetrics and Gynaecology
Empreinte numérique
Plonger dans les sujets de recherche 'Aneuploidy screening: What test should I use?'. Ensemble, ils forment une empreinte numérique unique.Citer
Berkowitz, R. L., Cuckle, H. S., Wapner, R., & D'Alton, M. E. (2006). Aneuploidy screening: What test should I use? Obstetrics and Gynecology, 107(3), 715-718. https://doi.org/10.1097/01.AOG.0000201976.00299.d2